Clinical Trials Browser

Pancreatic Cancer Non-resectable × Gemcitabine × Gastrointestinal × Clear all

NCT04156087 2024-09-19

MIMIPAC

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Non-resectable

NCT05047991 2021-09-17

Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Pancreatic Cancer Non-resectable